Cite

Addis A, Koren G. (2000). Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med30: 89–94.10.1017/S0033291799001270Open DOISearch in Google Scholar

Başterzi AD, Yazici K, Aslan E, Delialioğlu N, Taşdelen B, Tot Acar S, Yazici A. (2009). Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry33: 281–5.10.1016/j.pnpbp.2008.11.016Open DOISearch in Google Scholar

Bruschettini M, van den Hove DL, Gazzolo D, Bruschettini P, Blanco CE, Stein-busch HW. (2005). A single course of antenatal betamethasone reduces neurotrophic factor S100B concentration in the hippocampus and serum in the neonatal rat. Brain Res Dev Brain Res159: 113–8.Search in Google Scholar

Clarke C, Clarke K, Muneyyirci J, Azmitia E, Whitaker-Azmitia PM. (1996). Prenatal cocaine delays astroglial maturation: immunodensitometry shows increased markers of immaturity (vimentin and GAP-43) and decreased proliferation and production of the growth factor S-100. Brain Res Dev Brain Res91: 268–73.10.1016/0165-3806(95)00192-1Open DOISearch in Google Scholar

da-Silva VA, Altenburg SP, Malheiros LR, Thomaz TG, Lindsey CJ. (1999). Post-natal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Brazilian J Med Biol Res32: 93–8.Search in Google Scholar

de Bruijn ATCE, van Bakel HJA, Wijnen H, Pop VJM, van Baar AL. (2009). Prenatal maternal emotional complaints are associated with cortisol responses in toddler and preschool aged girls. Dev Psychobiol51: 553–63.10.1002/dev.20393Open DOISearch in Google Scholar

de Oliveira RA, Cunha GMA, Borges KDM, de Bruin GS, dos Santos-Filho EA, Viana GSB, de Bruin VMS. (2004). The effect of venlafaxine on behaviour, body weight and striatal monoamine levels on sleep-deprived female rats. Pharmacol Biochem Behav79: 499–506.10.1016/j.pbb.2004.09.001Open DOISearch in Google Scholar

Dennis C-L. (2005). Psychosocial and psychological interventions for prevention of postnatal depression: systematic review. BMJ331: 15–0.Search in Google Scholar

Drevets WC, Todd RD. (2005). Depression, mania and related disorders. In: Rubin E, Zorumski C (eds). Adult Psychiatry, 2nd edn. Blackwell, Oxford, pp. 91–129.Search in Google Scholar

Dubovický M, Császárová E, Brnoliaková Z, Ujházy E, Navarová J, Mach M. (2012). Effect of prenatal administration of venlafaxine on postnatal development of rat offspring. Interdiscip Toxicol5: 92–7.10.2478/v10102-012-0016-3Open DOISearch in Google Scholar

Duman RS, Malberg J, Nakagawa S, D‘Sa C. (2000). Neuronal plasticity and survival in mood disorders. Biol Psychiatry48: 732–9.10.1016/S0006-3223(00)00935-5Open DOISearch in Google Scholar

Einarson A, Choi J, Einarson TR, Koren G. (2009). Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry54: 242–6.Search in Google Scholar

Galbally M, Lewis AJ, Lum J, Buist A. (2009). Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study. Aust N Z J Psychiatry43(9): 846–54.Search in Google Scholar

Gazzolo D, Kornacka M, Bruschettini M, Lituania M, Giovannini L, Serra G, Majewska U, Michetti F. (2003). Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem49: 1215–8.Search in Google Scholar

Gausia K, Fisher C, Ali M, Oosthuizen J. (2009). Antenatal depression and suicidal ideation among rural Bangladeshi women: a community-based study. Arch Womens Ment Health12: 351–358.Search in Google Scholar

Gentile S. (2005). The safety of newer antidepressants in pregnancy and breastfeeding. Drug Saf28: 137–52.Search in Google Scholar

Gentile S. (2011). Suicidal mothers. J Inj Violence Res3: 90–7.Search in Google Scholar

Gerardin P, Wendland J, Bodeau N, Galin A, Bialobos S, Tordjman S, Mazet P, Darbois Y, Nizard J, Dommergues M, Cohen D. (2011). Depression during pregnancy: is the developmental impact earlier in boys? A prospective case-control study. J Clin Psychiatry72: 378–87.10.4088/JCP.09m05724blu21208585Open DOISearch in Google Scholar

Grote V, Vik T, von Kries R, Luque V, Socha J, Verduci E, Carlier C, Koletzko B. (2010). Maternal postnatal depression and child growth: a European cohort study. BMC Pediatr10: 14.Search in Google Scholar

Gump BB, Reihman J, Stewart P, Lonky E, Darvill T, Granger DA, Matthews KA. (2009). Trajectories of maternal depressive symptoms over her child’s life span: relation to adrenocortical, cardiovascular, and emotional functioning in children. Dev Psychopathol21: 207–25.10.1017/S0954579409000133458606619144231Open DOISearch in Google Scholar

Harmer CJ, Cowen PJ. (2013). “It”s the way that you look at it’--a cognitive neuropsychological account of SSRI action in depression. Philos Trans R Soc B Biol Sci368: 20120407–20120407.Search in Google Scholar

Hartley M, Tomlinson M, Greco E, Comulada WS, Stewart J, le Roux I, Mbewu N, Rotheram-Borus MJ. (2011). Depressed mood in pregnancy: prevalence and correlates in two Cape Town peri-urban settlements. Reprod Health8: 9.Search in Google Scholar

Herlenius E, Lagercrantz H. (2004). Development of neurotransmitter systems during critical periods. Exp Neurol190 Suppl: S8–21.Search in Google Scholar

Hesketh J, Baudier J. (1986). Evidence that S100 proteins regulate microtubule assembly and stability in rat brain extracts. Int J Biochem8: 691–5.Search in Google Scholar

Hollins K. (2007). Consequences of antenatal mental health problems for child health and development. Curr Opin Obstet Gynecol19: 568–72.10.1097/GCO.0b013e3282f1bf2818007135Open DOISearch in Google Scholar

Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry50: 260–5.10.1016/S0006-3223(01)01083-6Open DOISearch in Google Scholar

Karmaliani R, Asad N, Bann CM, Moss N, Mcclure EM, Pasha O, Wright LL, Goldenberg RL. (2009). Prevalence of Anxiety, Depression and Associated Factors Among Pregnant Women of Hyderabad, Pakistan. Int J Soc Psychiatry55: 414–424.10.1177/0020764008094645387517619592433Open DOISearch in Google Scholar

Källén B, Olausson PO. (2008). Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol. Drug Saf17: 801–6.10.1002/pds.157018314924Open DOISearch in Google Scholar

KINSELLA MT, MONK C. (2009). Impact of Maternal Stress, Depression and Anxiety on Fetal Neurobehavioral Development. Clin Obstet Gynecol52: 425–440.10.1097/GRF.0b013e3181b52df1371058519661759Open DOISearch in Google Scholar

Leung BMY, Kaplan BJ. (2009). Perinatal depression: prevalence, risks, and the nutrition link--a review of the literature. J Am Diet Assoc109: 1566–75.Search in Google Scholar

McDonald S, Wall J, Forbes K, Kingston D, Kehler H, Vekved M, Tough S. (2012). Development of a prenatal psychosocial screening tool for post-partum depression and anxiety. Paediatr Perinat Epidemiol26: 316–27.10.1111/j.1365-3016.2012.01286.x22686383Open DOISearch in Google Scholar

Mohammad KI, Gamble J, Creedy DK. (2011). Prevalence and factors associated with the development of antenatal and postnatal depression among Jordanian women. Midwifery27: e238–e245.10.1016/j.midw.2010.10.00821130548Open DOISearch in Google Scholar

Muzik M, Hamilton SE. (2016). Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression. Matern Child Health J20: 2268–2279.Search in Google Scholar

Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G. (2002). Child Development Following Exposure to Tricyclic Antidepressants or Fluoxetine Throughout Fetal Life: A Prospective, Controlled Study. Am J Psychiatry159: 1889–1895.Search in Google Scholar

Oberlander TF. (2012). Fetal serotonin signaling: setting pathways for early childhood development and behavior. J Adolesc Health51: S9–16.Search in Google Scholar

Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJD, Simpson EM. (2008). Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Mol Psychiatry13: 65–73.10.1038/sj.mp.400200717519929Open DOISearch in Google Scholar

Oyebode F, Rastogi A, Berrisford G, Coccia F. (2012). Psychotropics in pregnancy: safety and other considerations. Pharmacol Ther135: 71–7.Search in Google Scholar

Pawluski JL, Brummelte S, Barha CK, Crozier TM, Galea LAM. (2009). Effects of steroid hormones on neurogenesis in the hippocampus of the adult female rodent during the estrous cycle, pregnancy, lactation and aging. Front Neuroendocrinol30: 343–357.Search in Google Scholar

Pittenger C, Duman RS. (2008). Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology33: 88–109.10.1038/sj.npp.130157417851537Open DOISearch in Google Scholar

Popoli M, Gennarelli M, Racagni G. (2002). Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord4: 166–82.10.1034/j.1399-5618.2002.01159.x12180272Open DOISearch in Google Scholar

Rayen I, Steinbusch HWM, Charlier TD, Pawluski JL. (2013). Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring. Psychoneuroendocrinology38: 1618–29.Search in Google Scholar

Rayen I, van den Hove DL, Prickaerts J, Steinbusch HW, Pawluski JL. (2011). Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One6: e24003.Search in Google Scholar

Reis M, Källén B. (2010). Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med40: 1723–33.10.1017/S003329170999219420047705Open DOISearch in Google Scholar

Rothermundt M, Peters M, Prehn JH, Arolt V. (2003). S100B in brain damage and neurodegeneration. Microsc Res Tech60: 614–32.Search in Google Scholar

Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R. (2005). Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet (London, England)365: 482–7.Search in Google Scholar

Sheu FS, Azmitia EC, Marshak DR, Parker PJ, Routtenberg A. (1994). Glial-derived S100b protein selectively inhibits recombinant beta protein kinase C (PKC) phosphorylation of neuron-specific protein F1/GAP43. Brain Res Mol Brain Res21: 62–6.Search in Google Scholar

Shuey DL, Sadler TW, Lauder JM. (1992). Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology46: 367–78.10.1002/tera.14204604071412065Open DOISearch in Google Scholar

Talge NM, Neal C, Glover V. Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry48: 245–61.10.1111/j.1469-7610.2006.01714.x17355398Search in Google Scholar

Thormahlen GM. (2006). Paroxetine use during pregnancy: is it safe? Ann Pharmacother40: 1834–7.10.1345/aph.1H11616926304Open DOISearch in Google Scholar

Van den Bergh BRH, Mulder EJH, Mennes M, Glover V. (2005). Antenatal maternal anxiety and stress and the neurobehavioural development of the fetus and child: links and possible mechanisms. A review. Neurosci Biobehav Rev29: 237–58.Search in Google Scholar

Whitaker-Azmitia PM. (1991). Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev43(4): 553–61.Search in Google Scholar

Witt WP, Litzelman K, Cheng ER, Wakeel F, Barker ES. (2014). Measuring stress before and during pregnancy: a review of population-based studies of obstetric outcomes. Matern Child Health J18: 52–63.Search in Google Scholar

Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. (2009). The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry31: 403–413.10.1016/j.genhosppsych.2009.04.003309469319703633Open DOISearch in Google Scholar

eISSN:
1337-9569
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Pharmacology, Toxicology